Literature DB >> 18064937

[Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET)].

M J Noordzij1, L J M de Heide, T P Links, P L Jager, B H R Wolfenbuttel.   

Abstract

In 4 patients, an incidentaloma of the thyroid was found on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET). In the first patient, a 73-year-old man, a medullary thyroid carcinoma was discovered during the staging procedure ofa laryngeal carcinoma. In the second patient, an 81-year-old woman, a follicular thyroid carcinoma was found as a result of a FDG-PET evaluation of an adenocarcinoma of the lung. In the third patient, a 64-year-old woman, a papillary thyroid carcinoma was found during dissemination investigation after curative removal of an adrenocortical carcinoma. The last patient, a 78-year-old man, was found to have a thyroid incidentaloma on FDG-PET scan during staging ofa recurrence of a gastrointestinal stromal tumour. Thyroid incidentalomas are present on 1.2-2.3% of FDG-PET scans. Further diagnostic work-up of these lesions by fine needle aspiration is warranted since up to 50% are malignant. However, whether these malignant thyroid lesions are relevant is not always clear. Treatment depends on the primary disease for which the FDG-PET scan was initially made. This requires good evaluation and discussion with the patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18064937

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male.

Authors:  Stephen M Wanta; Marina Basina; Steven D Chang; Daniel T Chang; James M Ford; Ralph Greco; Kerry Kingham; Robert E Merritt; Pamela L Kunz
Journal:  Rare Tumors       Date:  2011-12-13

2.  Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer.

Authors:  Michele Podetta; Marc Pusztaszeri; Christian Toso; Michel Procopiou; Frédéric Triponez; Samira Mercedes Sadowski
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-22       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.